News (36)

Update
DateNews
Apr 14, 2017Xconomy - Bio Roundup: CRISPR Appeal, Bristol Deals, Stock Pumping & More
Apr 13, 2017Xconomy - Bristol Flips Remnants of Adnexus, iPierian to Roche, Biogen For $470M
Feb 15, 2017SEC - UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Dec 3, 2015Boston Tech Flash - True North will accelerate rare disease treatment development with $40M funding
Sep 21, 2015TechCrunch - Healthcare Is The Last Industry To Be Disrupted, Says KPCB’s Beth Seidenberg
Jun 23, 2015TechCrunch - M.D. Turned VC Beth Seidenberg To Talk Biotech Startups At Disrupt SF
May 12, 2015Xconomy - Bay Area Fund, Aligned With UC, Raises New To Cash To Seed Biotechs
Dec 16, 2014Fierce Biotech - Google Ventures splashes into life sciences with its $425M purse
Oct 23, 2014Fierce Biotech - Google Ventures taps Boston brains for EU unit, Big Pharma VCs back Forendo, Swiss IPO halted
Sep 29, 2014Xconomy - Ex-Elan Trio Grabs Their Former Employer’s Kinase Inhibitor Program
Jun 17, 2014Xconomy - With $22M, True North Points Toward Rare-Disease Clinical Trials
Jun 17, 2014FinSMEs - True North Therapeutics Raises $22M Series A Financing
May 14, 2014Xconomy - New Janssen Labs Incubator Could Bring Up to 50 Companies to South SF
Apr 29, 2014Fierce Biotech - Bristol-Myers targets neurodegenerative diseases in $725M deal to buy iPierian
Apr 29, 2014Xconomy - Seeking Tau: BMS Buys iPierian and Brain-Disease Program for $175M
Apr 29, 2014news.bms.com - Bristol-Myers Squibb Acquires iPierian, Inc.
Apr 29, 2014Xconomy - Bristol-Meyers Squibb Acquires iPierian for $725,000,000
Jan 13, 2014Xconomy - Rock Health Honors "Top 50" Digital Health Entrepreneurs
Sep 4, 2013FinSMEs - FinSMEs
Jan 31, 2013Xconomy - California Stem Cell Agency Shifts Focus to Clinical Treatments